Patents-Review.com
🔗 Permalink
Inventor profile of:

Andreas Haupt

City:

Ludwigshafen

Country:

Germany

Published Applications:

32

Last publication date:

2020-09-10

Top Assignees for applications by Andreas Haupt

The entities that hold a legal rights for patent applications filed by inventor Haupt Andreas:

Recent patent applications by Haupt Andreas

Andreas Haupt from Ludwigshafen, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-09-10
US20200283439A1
Chemistry; metallurgy

TRICYCLIC QUINOLINE AND QUINOXALINE DERIVATIVES

 #2 | 2020-02-06
US20200039930A1
Chemistry; metallurgy

PROLINE AMIDE COMPOUNDS AND THEIR AZETIDINE ANALOGUES CARRYING A SPECIFICALLY SUBSTITUTED BENZYL RADICAL

 #3 | 2020-01-02
US20200002354A1
Chemistry; metallurgy

HEXAHYDROPYRAZINOBENZ- OR -PYRIDO-OXAZEPINES CARRYING AN OXYGEN-CONTAINING SUBSTITUENT AND USE THEREOF IN THE TREATMENT OF 5-HT2C-DEPENDENT DISORDERS

 #4 | 2019-05-09
US20190135777A1
Chemistry; metallurgy

QUINOLINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO THE MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR

 #5 | 2019-03-07
US20190071443A1
Chemistry; metallurgy

TRICYCLIC QUINOLINE AND QUINOXALINE DERIVATIVES

 #6 | 2019-02-28
US20190062305A1
Chemistry; metallurgy

PYRIDYL OR PYRAZINYL COMPOUNDS CARRYING A METHYL-BOUND ALPHA-AMINO ACID AMIDE GROUP

 #7 | 2019-02-14
US20190048007A1
Chemistry; metallurgy

TRICYCLIC QUINOLINE AND QUINOXALINE DERIVATIVES

 #8 | 2018-11-29
US20180339996A1
Chemistry; metallurgy

HEXAHYDROPYRAZINOBENZ- OR -PYRIDO-OXAZEPINES CARRYING AN OXYGEN-CONTAINING SUBSTITUENT AND USE THEREOF IN THE TREATMENT OF 5-HT2C-DEPENDENT DISORDERS

 #9 | 2017-09-14
US20170260158A1
Chemistry; metallurgy

Quinoline compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HTreceptor

 #10 | 2017-06-08
US20170158693A1
Chemistry; metallurgy

HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL

 #11 | 2017-04-27
US20170112851A1
Human necessities

HEXAHYDRODIAZEPINOQUINOLINES CARRYING A SUBSTITUTED ALKYL RADICAL

 #12 | 2016-01-21
US20160016954A1
Chemistry; metallurgy

Tricyclic quinoline and quinoxaline derivatives

 #13 | 2015-09-17
US20150259346A1
Chemistry; metallurgy

Hexahydrodiazepinoquinolines carrying a substituted alkyl radical

 #14 | 2015-09-17
US20150259343A1
Chemistry; metallurgy

Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators

 #15 | 2014-10-09
US20140303176A1
Chemistry; metallurgy

Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor

 #16 | 2014-09-18
US20140275104A1
Chemistry; metallurgy

Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor

 #17 | 2014-03-20
US20140080816A1
Chemistry; metallurgy

Tricyclic quinoline and quinoxaline derivatives

 #18 | 2014-03-20
US20140080814A1
Chemistry; metallurgy

Tricyclic quinoline and quinoxaline derivatives

 #19 | 2013-01-17
US20130018047A1
Chemistry; metallurgy

N-PHENYL-(PIPERAZINYL OR HOMOPIPERAZINYL)-BENZENESULFONAMIDE OR BENZENESULFONYL-PHENYL-(PIPERAZINE OR HOMOPIPERAZINE) COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR

 #20 | 2013-01-03
US20130005703A1
Chemistry; metallurgy

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HTreceptor

 #21 | 2012-06-07
US20120142674A1
Chemistry; metallurgy

N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HTreceptor

 #22 | 2012-05-24
US20120129883A1
Chemistry; metallurgy

Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HTreceptor

 #23 | 2012-02-16
US20120040969A1
Chemistry; metallurgy

N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

 #24 | 2011-12-29
US20110319421A1
Chemistry; metallurgy

BENZENESULFONAMIDE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR

 #25 | 2011-01-13
US20110009380A1
Chemistry; metallurgy

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

 #26 | 2010-12-09
US20100311755A1
Chemistry; metallurgy

1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine Dreceptor

 #27 | 2010-11-18
US20100292271A1
Chemistry; metallurgy

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HTreceptor

 #28 | 2010-11-18
US20100292221A1
Chemistry; metallurgy

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HTreceptor

 #29 | 2010-11-18
US20100292220A1
Chemistry; metallurgy

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HTreceptor

 #30 | 2010-11-04
US20100280014A1
Chemistry; metallurgy

N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HTreceptor

 #31 | 2010-08-19
US20100210664A1
Chemistry; metallurgy

BENZENESULFONAMIDE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR

 #32 | 2010-06-03
US20100137280A1
Chemistry; metallurgy

Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HTreceptor
InventorID:

42463 ⎘